RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 1 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $100,000 | -66.9% | 117,446 | +114.0% | 0.00% | – |
| Q1 2022 | $302,000 | -66.1% | 54,880 | -40.3% | 0.00% | -100.0% |
| Q4 2021 | $890,000 | -51.8% | 91,916 | -10.9% | 0.00% | -50.0% |
| Q3 2021 | $1,845,000 | -49.4% | 103,194 | -30.9% | 0.00% | -33.3% |
| Q2 2021 | $3,647,000 | -37.0% | 149,419 | -31.6% | 0.00% | -40.0% |
| Q1 2021 | $5,792,000 | +373.6% | 218,575 | +35.7% | 0.01% | +400.0% |
| Q4 2020 | $1,223,000 | +554.0% | 161,097 | +331.3% | 0.00% | – |
| Q3 2020 | $187,000 | +79.8% | 37,349 | +114.8% | 0.00% | – |
| Q2 2020 | $104,000 | – | 17,391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |